WASHINGTON (AP) — Scientists stumbled onto a hint that measuring a toxic protein tied to Alzheimer’s disease just might one day be useful in diagnosing a different brain disease in football players and others who have suffered repeated blows to the head.
Doctors evaluate symptoms such as mood swings and memory loss to try to tell if patients may have CTE, or chronic traumatic encephalopathy, a disease linked to concussions and other brain trauma. But
other diseases cause similar symptoms, and a CTE diagnosis can only be confirmed by examining the brain after death.
Now two small studies are highlighting a new clue — that a blood test being developed to spot abnormal tau in the brains of Alzheimer’s patients seems to also detect buildup of that protein in people with advanced CTE.
Tau normally supports neurons but in Alzheimer’s, it tangles inside those nerve cells. Scientists are developing a blood test to track those tangles by detecting a particular tau fragment called eMTBR-tau243. But researchers at Washington University in St. Louis got a surprise when using autopsy records to study the new test – finding someone with high levels of that biomarker who didn’t have Alzheimer’s but CTE instead.
The researchers turned to a larger collection of autopsied brain and blood samples, eventually testing blood stored from 11 people classified as having CTE.
Compared to samples stored from healthy people, levels of eMTBR-tau243 were higher in those with advanced CTE, said study co-author Chihiro Sato, a WashU assistant neurology professor. That biomarker couldn’t reliably identify early-stage CTE, the research team reported at a dementia meeting in Japan last week.
Separately, researchers at Boston University and Arizona’s Banner Health were studying the same question using blood stored from 21 former professional or school football players who also donated their brain for research after death. Autopsies found 16 died with advanced CTE, two with earlier-stage CTE and three didn’t have the disease.
Blood levels of that tau biomarker were significantly higher in the athletes with advanced CTE, the researchers reported Thursday at a scientific meeting in Boston. Adding to the complexity, five of those with CTE also had Alzheimer’s disease, resulting in the highest levels of that tau biomarker.
Both studies were published in the medical journal JAMA.
The possible CTE link is interesting but very preliminary, requiring much larger studies to see if there’s a real connection, cautioned Northwestern University neuropathologist Dr. Rudolph Castellani, who wasn’t involved with the research.
Abnormal tau is found in several additional brain diseases, which can overlap in older adults. Moreover, tau buildup in CTE is different from the type that occurs in Alzheimer’s, Drs. Günter Höglinger and Carla Palleis of Germany’s Ludwig Maximilian University of Munich wrote in an accompanying editorial in the journal.
They also stressed the need for far more research, while saying the two studies together “represent an important step” in the quest to one day detect CTE in living patients.
—-
The Associated Press’ health and science coverage receives financial support from the AP Fund for Journalism and private foundations. AP is solely responsible for all content. Find AP’s standards for working with philanthropies, a list of supporters and funded coverage areas at AP.org

















